2016年厦门市常规免疫接种率监测与评价  

Surveillance and evaluation of routine immunization coverage rate in Xiamen City in 2016

作　　者：谢群[1] 马姗姗[1] 郑惠能[1] 池益强[1] XIE Qun;MA Shah-shah;ZHENG Hui-neng;CHI Yi-qiang(Immunization Programme Department,X iamen Center for Disease Control and Prevention,Xiamen Fujian,361021,China)

机构地区：[1]厦门市疾病预防控制中心免疫规划科,福建厦门361021

出　　处：《职业与健康》2018年第22期3115-3119,共5页Occupation and Health

摘　　要：目的了解2016年厦门市常规免疫接种监测工作情况,评价常规免疫报告接种率水平并分析原因。方法运用Excel 2007进行数据分析,利用比值(R)评价法、估算接种率、差值(D)评价法对厦门市2016年常规免疫报告接种率质量进行评价。结果 2016年常规免疫报表报告完整率及及时率均为100%(216/216);2016年厦门市除A+C群流脑疫苗(MenA+C)外其它疫苗报告接种率在95.04%~100.00%之间,集美区及思明区MenA+C报告接种率较低,最低为75.14%。R值评价市级7个R值均可信,区级可疑、不可信R值分别有4、2个,其余R值均可信。加强免疫估算接种率,市、区级百白破三联疫苗第4剂次(DPT 4)、麻腮风三联疫苗(MMR)、乙脑疫苗第2剂次(JE 2)、脊髓灰质炎疫苗第4剂次(OPV 4)均在93%以上,白破二联疫苗(DT)、MenA+C 1及MenA+C 2均低于80%,其中市级MenA+C 2低于65%,同安区MenA+C 2、翔安区DT及MenA+C 2均低于60%,翔安区MenA+C 2为46.72%。D值评价中,市级DPT 4、MMR、JE 2的D值可信,OPV 4 D值可疑,DT、MenA+C 1及MenA+C 2的D值不可信。区级除集美区DPT 4、JE 2的D值可疑外,其他各区DPT 4、MMR 1、JE 2 D值均可信;除同安区的OPV 4 D值可信外,其他各区MenA+C 1、OPV 4 D值均为可疑或不可信;除集美区MenA+C 2的D值为可疑外,其他各区DT、MenA+C 2 D值均不可信。结论厦门市常规免疫报告接种率较2014、2015年有小幅度下降,但仍达到国家要求。MenA+C报告接种率较其他疫苗低,主要是由于一类疫苗短缺及二类疫苗接受度差等原因。R值评价及D值评价提示,厦门市今年常规免疫监测工作质量有提高,但仍存在摸底不准确、疫苗接种率报告虚高等问题。免疫规划工作需要政府、卫生、教育等各部门合作,群众的支持及参与,方能提高接种率,保障健康。[Objective] To understand the surveillance of routine immunization in Xiamen City in 2016, evaluate the level of reported coverage rate in routine immunization and analyze the reasons. [Methods] Excel 2007 was applied for data analysis. The quality of routine immunization report coverage rate in Xiamcn City in 2016 was evaluated by ratio （R） evaluation,estimated vaccination rate and difference （ D ） evaluation.[Results] In 2016, the integrity rate and timely rate of routine immunization reports were both 100%（216/216）. Except f meningitis serogronp A and C vaccine （MenA＋C）, the reported coverage rates of other vaccines were 95.04%-100.00%. The reported coverage rates in Jimei District and Siming District were relatively low,and the lowest was 75.14%. R evaluation results showed that seven R values at the municipal level were all credible,there were 4 suspicious R values and 2 unreliable R values at the district level,and the rest were credible. At municipal level and district level, the estimated coverage rates of enhanced immunization of the fourth dose of diphtheria-tetanus-pertussis vaccine （DPT）, meales- mumps-rubella vaccine（MMR）, the second dose of encephalitis B vaccine （JE 2）, the fourth dose of poliomyelitis vaccine （OPV 4） were higher than 93%. The estimated coverage rates of diphtheria-tetanus vaccine （DT）, MenA＋C 1 and MenA＋C 2 were lower than 80%, of which the rate of MenA ＋C 2 at the municipal level was lower than 65%, the rates of MenA ＋C 2 in Tongan District, DT and MenA＋C 2 in Xiang＇an District were lower than 60%, while the rate of MenA＋C 2 in Xiang＇an District was 46.72%. In D evaluation, the D values of DPT 4, MMR and JE 2 at the municipal level were credible, D value of OPV 4 was suspicious,and the D values of DT, MenA＋C 1 and MenA＋C 2 were not credible. At the district level, except for the D value of DPT 4 and JE 2 in Jimei District, the values of DPT 4, MMR 1 and JE 2 in other districts were credible. Except for the D value of OPV 4

关 键 词：常规免疫 接种率 监测 评价 

分 类 号：R186[医药卫生—流行病学]